Summary - A new market study, titled “Global Point-of-Care Infectious Disease Diagnostics/Testing Market Professional Survey Report 2019” has been featured on WiseGuyReports.
The global Point-of-Care Infectious Disease Diagnostics/Testing market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Point-of-Care Infectious Disease Diagnostics/Testing volume and value at global level, regional level and company level. From a global perspective, this report represents overall Point-of-Care Infectious Disease Diagnostics/Testing market size by analyzing historical data and future prospect.
ALSO READ: https://icrowdnewswire.com/2020/07/14/point-of-care-infectious-disease-diagnostics-testing-market-report-2020-2026-by-supply-demand-consumption-sale-price-share-revenue-and-top-manufacturers/
Regionally, this report categorizes the production, apparent consumption, export and import of Point-of-Care Infectious Disease Diagnostics/Testing in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Point-of-Care Infectious Disease Diagnostics/Testing manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Thermo Fisher Scientific Inc
F. Hoffmann-La Roche Ltd
BD & Company
Chembio Diagnostics Inc.
Quest Diagnostics Inc.
Bio-Rad Labs Inc.
Sight Diagnostics Ltd.
Segment by Regions
Segment by Type
Clostridium difficile POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
Segment by Application
Assisted Living Healthcare Facilities
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +162-825-80070 (US)
Ph: +44 203 500 2763 (UK)